Bdpazo 200mg Tablet

About

Bdpazo 200mg Tablet is a non-steroidal anti-inflammatory drug (NSAID) primarily indicated for its potent analgesic, anti-inflammatory, and antipyretic effects. Its mechanism of action involves the inhibition of cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2, which are crucial for the biosynthesis of prostaglandins. Prostaglandins are key mediators in the pathways of pain, inflammation, and fever. By reducing prostaglandin synthesis, Bdpazo effectively mitigates symptoms associated with various inflammatory and painful conditions, offering symptomatic relief and improving patient comfort.

This medication is absorbed orally, reaching peak plasma concentrations within a few hours. It undergoes extensive hepatic metabolism and is primarily excreted via the renal route. Due to its systemic effects, careful consideration of patient comorbidities, especially gastrointestinal, cardiovascular, and renal health, is essential. Adherence to prescribed dosages and monitoring for potential adverse reactions are crucial for optimizing therapeutic outcomes and ensuring patient safety during treatment.

Uses

• Relief of mild to moderate pain.
• Reduction of inflammation in musculoskeletal disorders.
• Management of fever.
• Symptomatic treatment of dysmenorrhea.

Directions For Use

Take one tablet orally with food or milk to minimize gastrointestinal irritation. Do not crush or chew the tablet.

Benefits

• Effective relief from pain.
• Reduces inflammation and swelling.
• Helps to lower elevated body temperature.
• Improves joint mobility in inflammatory conditions.
• Convenient oral dosage form.
• Provides rapid onset of action for symptom control.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Heartburn
• Dizziness
• Headache
• Skin rash
• Fluid retention
• Increased blood pressure
• Gastric ulcers (with prolonged use)

Safety Measures

• Alcohol - Concurrent use of alcohol with Bdpazo may significantly increase the risk of gastrointestinal bleeding and liver toxicity. It is strongly advised to limit or avoid alcohol consumption during treatment.
• Pregnancy - Bdpazo is generally not recommended during pregnancy, particularly in the third trimester, due to potential risks such as premature closure of the fetal ductus arteriosus and renal dysfunction. Consult a physician.
• Breastfeeding - Small amounts of Bdpazo may be excreted into breast milk. Use with caution and only if clearly necessary, under strict medical supervision, weighing potential risks to the nursing infant.
• Liver - Patients with pre-existing liver impairment should use Bdpazo with extreme caution, as it is extensively metabolized in the liver. Dose adjustments and regular monitoring of liver function tests may be required.
• Kidney - Bdpazo can impair renal function, especially in dehydrated, elderly patients, or those with pre-existing kidney disease. Close monitoring of kidney function is essential during therapy.
• Lung - While not a primary respiratory drug, NSAIDs can sometimes precipitate or exacerbate asthma attacks in aspirin-sensitive individuals. Patients with asthma should use with caution and report any worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.